[The effect of nerobolyl on experimental myocardial infarct in rabbits with cholesterol atherosclerosis].
D000818:Animals; D001161:Arteriosclerosis / Q000150:complications*; D001706:Biopsy; D002784:Cholesterol / Q000378:metabolism; D004036:Diet, Atherogenic; D006937:Hypercholesterolemia / Q000150:complications* / Q000188:drug therapy*; D008696:Methandrostenolone / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000150:complications / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D010713:Phosphatidylcholines / Q000378:metabolism; D011817:Rabbits; D012709:Serum Albumin / Q000378:metabolism; D012712:Serum Globulins / Q000378:metabolism; D014882:Water-Electrolyte Balance
D010713:Phosphatidylcholines; D012709:Serum Albumin; D012712:Serum Globulins; D002784:Cholesterol; D008696:Methandrostenolone
Vliianie nerobolila na eksperimental'nyĭ infarkt miokarda u krolikov s kholesterinovym aterosklerozom.